Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;97(2):785-797.
doi: 10.1038/s41390-024-03328-8. Epub 2024 Jun 29.

Integrative metabolomics dictate distinctive signature profiles in patients with Tetralogy of Fallot

Affiliations

Integrative metabolomics dictate distinctive signature profiles in patients with Tetralogy of Fallot

Ying Li et al. Pediatr Res. 2025 Feb.

Abstract

Background: Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease (CCHD) with multifactorial etiology. We aimed to investigate the metabolic profiles of CCHD and their independent contributions to TOF.

Methods: A cohort comprising 42 individuals with TOF and atrial septal defect (ASD) was enrolled. Targeted ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) was employed to systematically analyze metabolite levels and identify TOF-associated metabolic profiles.

Results: Of 370 identified metabolites in tissue and 284 in plasma, over one-third of metabolites showed an association with microbiome. Differential metabolic pathways including amino acids biosynthesis, ABC (ATP-binding cassette) transporters, carbon metabolism, and fatty acid biosynthesis, shed light on TOF biological phenotypes. Additionally, ROC curves identified potential biomarkers, such as erythronic acid with an AUC of 0.868 in plasma, and 3-β-hydroxy-bisnor-5-cholenic acid, isocitric acid, glutaric acid, ortho-Hydroxyphenylacetic acid, picolinic acid with AUC close to 1 in tissue, whereas the discriminative performance of those substances significantly improved when combined with clinical phenotypes.

Conclusions: Distinct metabolic profiles exhibited robust discriminatory capabilities, effectively distinguishing TOF from ASD patients. These metabolites may serve as biomarkers or key molecular players in the intricate metabolic pathways involved in CCHD development.

Impact: Distinct metabolic profiles exhibited robust discriminatory capabilities, effectively distinguishing Tetralogy of Fallot from atrial septal defect patients. Similar profiling but inconsistent differential pathways between plasma and tissue. More than one-third metabolites in plasma and tissue are associated with the microbiome. The discovery of biomarkers is instrumental in facilitating early detection and diagnosis of Tetralogy of Fallot. Disturbed metabolism offers insights into interpretation of pathogenesis of Tetralogy of Fallot.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Informed consent: According to the guidelines in the Declaration of Helsinki, all patients and their guardians were informed of the study and signed informed consent.

References

    1. Villafañe, J. et al. Hot topics in tetralogy of Fallot. J. Am. Coll. Cardiol. 62, 2155–2166 (2013). - DOI - PubMed
    1. Shinebourne, E. A., Babu-Narayan, S. V. & Carvalho, J. S. Tetralogy of Fallot: From fetus to adult. Heart (Br. Card. Soc.) 92, 1353–1359 (2006). - DOI
    1. Apitz, C., Webb, G. D. & Redington, A. N. Tetralogy of Fallot. Lancet (Lond., Engl.) 374, 1462–1471 (2009). - DOI
    1. Starr, J. P. Tetralogy of Fallot: Yesterday and today. World J. Surg. 34, 658–668 (2010). - DOI - PubMed
    1. Michielon, G. et al. Genetic Syndromes and outcome after surgical correction of tetralogy of Fallot. Ann. Thorac. Surg. 81, 968–975 (2006). - DOI - PubMed

LinkOut - more resources